115
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Trends of Drug-Resistant Tuberculosis in an Urban and a Rural Area in China: A 10-Year Population-Based Molecular Epidemiological Study

, , ORCID Icon, ORCID Icon, , & show all
Pages 919-926 | Received 15 Sep 2023, Accepted 23 Feb 2024, Published online: 08 Mar 2024

References

  • WHO. Global Tuberculosis Report 2022. Geneva, Switzerland: World Health Organization; 2022.
  • Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008;31(6):1256–1260. doi:10.1183/09031936.00131107
  • Mathew TA, Ovsyanikova TN, Shin SS, et al. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int J Tuberc Lung Dis. 2006;10(8):857–863.
  • Santha T, Garg R, Frieden TR, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6(9):780–788.
  • Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis. 1997;24 Suppl 1:S121–S130. doi:10.1093/clinids/24.supplement_1.s121
  • Sylverken AA, Kwarteng A, Twumasi-Ankrah S, et al. The burden of drug resistance tuberculosis in Ghana; results of the First National Survey. PLoS One. 2021;16(6):e0252819. doi:10.1371/journal.pone.0252819
  • Quispe N, Asencios L, Obregon C, et al. The fourth national anti-tuberculosis drug resistance survey in Peru. Int J Tuberc Lung Dis. 2020;24(2):207–213. doi:10.5588/ijtld.19.0186
  • Diande S, Badoum G, Combary A, et al. Multidrug-Resistant Tuberculosis in Burkina Faso from 2006 to 2017: results of National Surveys. Eur J Microbiol Immunol. 2019;9(1):23–28. doi:10.1556/1886.2018.00029
  • Nhung NV, Hoa NB, Sy DN, Hennig CM, Dean AS. The fourth national anti-tuberculosis drug resistance survey in Viet Nam. Int J Tuberc Lung Dis. 2015;19(6):670–675. doi:10.5588/ijtld.14.0785
  • Bojorquez-Chapela I, Backer CE, Orejel I, et al. Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis. Int J Tuberc Lung Dis. 2013;17(4):514–519. doi:10.5588/ijtld.12.0167
  • Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. New Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa1108789
  • Li Z, Liu F, Chen H, et al. A five-year review of prevalence and treatment outcomes of pre-extensively drug-resistant plus additional drug-resistant tuberculosis in the Henan Provincial Tuberculosis Clinical Medicine Research Center. J Global Antimicrob Resist. 2022;31:328–336. doi:10.1016/j.jgar.2022.09.010
  • Pang Y, Lu J, Huo F, et al. Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: a five-year review. J Infect. 2017;75(5):433–440. doi:10.1016/j.jinf.2017.08.005
  • Chen L, Wang X, Jia X, et al. Investigation of 3-year inpatient TB cases in Zunyi, China: increased TB burden but improved bacteriological diagnosis. FRONT PUBLIC HEALTH. 2022;10:941183. doi:10.3389/fpubh.2022.941183
  • Song WM, Li YF, Ma XB, et al. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018. Respir Res. 2019;20:223. doi:10.1186/s12931-019-1199-3
  • Zhou M, Liu S, Li Q, et al. Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: a retrospective study. PLoS One. 2018;13(12):e0209902. doi:10.1371/journal.pone.0209902
  • Wu B, Zhang L, Liu Z, et al. Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013. Glob Health Action. 2017;10:1293925. doi:10.1080/16549716.2017.1293925
  • Bouzouita I, Cabibbe AM, Trovato A, et al. Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016. Emerging Infect Dis. 2019;25:538–546. doi:10.3201/eid2503.181370
  • Edokimov K, Yamada Y, Dary C, et al. Whole-genome sequencing of Mycobacterium tuberculosis from Cambodia. Sci Rep. 2022;12(1):7693. doi:10.1038/s41598-022-10964-9
  • Zhao B, Liu C, Fan J, et al. Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China. MICROBIOL SPECTR. 2022;10(5):e0240521. doi:10.1128/spectrum.02405-21
  • Phelan JE, O’Sullivan DM, Machado D, et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 2019;11(1):41. doi:10.1186/s13073-019-0650-x
  • Dohal M, Porvaznik I, Prso K, Rasmussen EM, Solovic I, Mokry J. Whole-genome sequencing and Mycobacterium tuberculosis: challenges in sample preparation and sequencing data analysis. Tuberculosis. 2020;123:101946. doi:10.1016/j.tube.2020.101946
  • Li M, Guo M, Peng Y, et al. High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study. Emerg Microbes Infect. 2022;11(1):2102–2111. doi:10.1080/22221751.2022.2112912
  • Li M, Lu L, Jian Q, et al. Genotypic and Spatial Analysis of Transmission Dynamics of Tuberculosis in Shanghai, China: A 10-Year Prospective Population-Based Surveillance Study. Lancet Reg Health West Pac; 2024.
  • Li M, Lu L, Guo M, et al. Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China. Emerg Microbes Infect. 2023;12(1):2192301. doi:10.1080/22221751.2023.2192301
  • Chen Y, Ji L, Liu Q, et al. Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis. J Infect Dis. 2021;224(5):889–893. doi:10.1093/infdis/jiab011
  • Langmead B, Wilks C, Antonescu V, Charles R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics. 2019;35(3):421–432. doi:10.1093/bioinformatics/bty648
  • Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and Samtools. Bioinformatics. 2009;25(16):2078–2079. doi:10.1093/bioinformatics/btp352
  • Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568–576. doi:10.1101/gr.129684.111
  • Yang T, Gan M, Liu Q, et al. SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission. Brief Bioinform. 2022;23(2). doi:10.1093/bib/bbac030
  • Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17(3):275–284. doi:10.1016/S1473-3099(16)30418-2
  • World Health Organization. MDR_RR_TB_burden_estimates.csv. Global tuberculosis report; 2022. https://www.who.int/teams/global-tuberculosis-programme/data. Accessed March 4, 2024.
  • Yang C, Lu L, Warren JL, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018;18(7):788–795. doi:10.1016/S1473-3099(18)30218-4
  • Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med. 2015;3(12):963–972. doi:10.1016/S2213-2600(15)00458-0
  • World Health Organization. Tuberculosis profile: china; 2022. https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22CN%22. Accessed March 4, 2024.